Cell Transplant 25(5):849861 Matsuyama N, Shimizu S, Ueda K, Suzuki T, Suzuki S, Miura R, Katayama A, Ando M et al (2022) Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial
Most gastrointestinal symptoms are mild to moderate in severity and tend to diminish over time as the body adjusts to the medication
Variations in tissue selectivity amongst insulin secretagogues: a systematic review
Oxidative stress, modified lipoproteins, and other lesion factors (bioactive lipids, pattern recognition molecules, cytokines) are capable of inducing inflammation via receptors (54,55,60)
People often feel full sooner during meals, hunger signals become less intense, and cravings become easier to manage